Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Research has shown that losing just 4.5kg can shrink visceral fat by as much as 30%
The website will direct patients to drugmakers direct-to-consumer platforms, where some of their products will be available at a discount for cash-paying patients, say, in the deductible phase of their insurance, or those who are not insured (either no health insurance at all, or not insured for obesity medicines)
Key Takeaways Starting dose: 2 mg once weekly for 4 weeks Titration pace: Increase every 4 weeks: 2 4 8 12 mg Maximum dose: 12 mg weekly (Phase 2/3 clinical trial protocol) Total ramp-up: ~16 weeks to reach maximum dose Mechanism: Triple agonist (GLP-1 + GIP + Glucagon), the only triple-agonist in late-stage trials Weight loss: Up to 24.2% at 48 weeks (Phase 2) and 28.7% at 68 weeks (Phase 3 TRIUMPH-4) GLP-3 Retatrutide Dosage Chart Free printable reference chart showing the retatrutide (GLP-3) clinical trial titration schedule from 2 mg to 12 mg weekly
In days and weeks, data is collected on cell/tumor morphology, migration, and survival, and analyzed using techniques such as Unsupervised AI Machine Learning
Concurrently, GHK-Cu influences MAPK pathways including ERK1/2, p38, and JNK, with effects varying based on cellular context and stimulation conditions
